Aspira Women’s Health Investor Day OvaWatch and EndoCheck Market Opportunities
About The Event
Join us for a virtual Investor Day with Aspira Women’s Health hosted by Nicole Sandford, President and CEO, Dr. Ryan Phan, Chief Scientific and Operating Officer, and Dr. Charles Dunton, Chair of Aspira’s Scientific Advisory Board. Featured experts include:
Dr. Kevin Elias, Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and Director of Gynecologic Oncology Laboratory at Brigham and Women’s Hospital in Boston, Massachusetts.
Dr. Tamika Sea, FACOG, obstetrician, gynecologist and Founder/Owner of Advanced Women’s Care Center in Atlanta, Georgia.
We will discuss the current state of ovarian cancer with a particular focus on diagnostic and clinical care gaps, and how healthcare providers use Aspira’s noninvasive tests to detect cancer earlier, prevent premature or unnecessary surgery, and reduce surgical backlog. The program will also discuss the expansion of Aspira’s OvaWatch test for serial monitoring to enhance clinical management of adnexal masses.
The presentation will highlight challenges related to the diagnosis of endometriosis, along with Aspira’s proprietary and collaborative research efforts to develop the first portfolio of non-invasive diagnostic tools for the estimated six million+ U.S. women that suffer from this debilitating gynecologic disease.
A live question and answer session will follow the presentations.